CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...
BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety ...
LONDON, July 9 (Reuters) - Britain became the first country in the world to approve Allergan Inc's anti-wrinkle injection Botox as a treatment for migraine on Friday, opening up a new market for the ...
When Irvine drug maker Allergan Inc. reported its first-quarter results, Chief Executive David Pyott mentioned that it’s gotten two-thirds of commercial insurance plans to cover Botox injections to ...
–All primary and secondary endpoints were met for second Phase 3 study (M21-310) and results were consistent with findings from first Phase 3 study (M21-309). –Results support onabotulinumtoxinA as a ...
"At my practice, we leverage Allē to ensure BOTOX ® Cosmetic Day is successful for patients looking to explore the results that can be achieved with BOTOX ® Cosmetic," said Dr. David Shafer, double ...
CHICAGO -- The US Centers for Disease Control and Prevention issued an advisory last month about the risks of counterfeit or mishandled Botox injections after dangerous fake versions of the product ...
The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...
Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A federal jury July 18 said Revance Therapeutics' skin ...
A Virginia federal court jury has ordered Irvine drug maker Allergan Inc. to pay $212 million to a man who said he got permanent brain damage after being injected with Botox to treat cramps and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback